Your browser doesn't support javascript.
loading
[Pharmacotherapeutic aspects of femoral head necrosis]. / Pharmakotherapeutische Aspekte der Femurkopfnekrose.
Tarner, I H; Dinser, R; Müller-Ladner, U.
Afiliação
  • Tarner IH; Lehrstuhl für Innere Medizin mit Schwerpunkt Rheumatologie der Justus-Liebig Universität Giessen.
Orthopade ; 36(5): 446-50, 2007 May.
Article em De | MEDLINE | ID: mdl-17476478
ABSTRACT
Avascular necrosis (AVN) of the hip is one of the unsolved problems in orthopedics, especially with regard to drug therapy. Only a few studies exist using a long-term approach with vasodilating agents such as prostaglandins, anticoagulants, hormones, as well as lipid lowering and bone protective drugs such as bisphosphonates. However, using these medications several studies have demonstrated a significant reduction in pain, in the destruction of the femoral head as well as in overall disability. This resulted in a reduced need for joint replacement in patients with AVN and to a substantial improvement in quality of life. Of note, drug therapy should be initiated in the early phases of AVN as later stages appear to be less responsive to medication.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vasodilatadores / Artralgia / Difosfonatos / Conservadores da Densidade Óssea / Necrose da Cabeça do Fêmur / Hipolipemiantes Tipo de estudo: Etiology_studies Aspecto: Patient_preference Limite: Humans Idioma: De Revista: Orthopade Ano de publicação: 2007 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vasodilatadores / Artralgia / Difosfonatos / Conservadores da Densidade Óssea / Necrose da Cabeça do Fêmur / Hipolipemiantes Tipo de estudo: Etiology_studies Aspecto: Patient_preference Limite: Humans Idioma: De Revista: Orthopade Ano de publicação: 2007 Tipo de documento: Article